Inventor · disambiguated record
Alexandra Lantermann
Also filed as: LANTERMANN ALEXANDRA
1 granted patent·7 pending applications·6 citations·filing 2017–2022
27Inventor score
Top patents by PatentIndex Score
8 records- 0188US10457740B1Methods and compositions for treating cancer using P2RX2 inhibitorsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2018·Granted Oct 29, 2019·6 cites·1 claims
- 0269US2021177823A1Neuromodulating compositions and related therapeutic methods for the treatment of cancerFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Application pending·0 cites
- 0369US2021154272A1Neuromodulating compositions and related therapeutic methods for the treatment of cancer by modulating an anti-cancer immune responseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Application pending·0 cites
- 0462US2021283217A1Neuromodulating compositions and related therapeutic methods for the treatment of inflammatory and autoimmune diseasesFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2017·Application pending·0 cites
- 0559US2019240293A1Neuromodulating compositions and related therapeutic methods for the treatment of cancer by modulating an anti-cancer immune responseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2017·Application pending·0 cites
- 0652US2023035892A1Methods and compositions for treating cancerFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Application pending·0 cites
- 0750US2024174637A1Degraders of grk2 and uses thereofPIIZZI GRAZIA·Filed 2022·Application pending·0 cites
- 0846US2023009608A1Grk2 inhibitors and uses thereofCYGNAL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alexandra Lantermann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →